Anzeige
Mehr »
Samstag, 07.02.2026 - Börsentäglich über 12.000 News
Der Shakeout: Silber hat genau das getan, was echte Bullenmärkte immer tun - es hat die Touristen abgeschüttelt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DVUC | ISIN: NZAFTE0001S4 | Ticker-Symbol:
Branche
Versorger
Aktienmarkt
AUSTRALIEN
1-Jahres-Chart
AFT PHARMACEUTICALS LIMITED Chart 1 Jahr
5-Tage-Chart
AFT PHARMACEUTICALS LIMITED 5-Tage-Chart

Aktuelle News zur AFT PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
15.01.Stablepharma Ltd: Stablepharma and AFT Pharmaceuticals (NZX: AFT; ASX: AFP) partner to address multi-billion dollar anti-infective and oncology therapeutics market364LONDON, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Stablepharma Limited, specialists in thermostable formulations, today announced a development and option-to-license agreement with AFT Pharmaceuticals to develop...
► Artikel lesen
AFT PHARMACEUTICALS Aktie jetzt für 0€ handeln
14.01.AFT PHARMACEUTICALS LIMITED: December Quarter FY 2026 Investor Update1
20.11.25Health Check: AFT Pharmaceuticals girds for major iron deficiency therapy trial1
20.11.25AFT Pharmaceuticals jumps +10% on $115M interim FY26 record revenue1
20.11.25AFT Pharma unveils record revenues of $115 million on global expansion1
19.11.25AFT PHARMACEUTICALS LIMITED: AFT delivers 10th consecutive first half revenue increase2
18.11.25AFT PHARMACEUTICALS LIMITED: AFT CFO Malcolm Tubby to retire Simon Bosley CFO Designate-
18.11.25AFT PHARMACEUTICALS LIMITED: AFT CFO Malcolm Tubby to retire; Simon Bosley CFO Designate1
27.10.25Listen: From the Wire - AFT Pharmaceuticals CEO and Founder Hartley Atkinson2
23.10.25AFT PHARMACEUTICALS LIMITED: AFT to announce half year interim results Nov 20-
25.09.25AFT Pharma: FY27 revenue expected to hit $300M, positive iron IV results in2
24.09.25AFT PHARMACEUTICALS LIMITED: September Quarter FY2026 Investor Update-
01.09.25AFT PHARMACEUTICALS LIMITED: Disclosure of Directors and Senior Managers Relevant Interes-
01.09.25AFT PHARMACEUTICALS LIMITED: Disclosure of Directors and Senior Managers Relevant Int-
03.07.25AFT Pharmaceuticals - Making progress on growth strategy472AFT Pharmaceuticals has provided an investor update for Q2 CY25 (Q1 FY26), summarising material progress made across its global expansion and R&D-driven growth strategy. The highlight of the period...
► Artikel lesen
03.06.25AFT Pharmaceuticals - Setting the stage for sustained long-term growth511AFT Pharmaceuticals reported FY25 revenues of N Z$208m, posting a strong recovery in H2, with dissipating headwinds and traditional H2 seasonality offsetting the softer H1 performance. H225 revenues...
► Artikel lesen
16 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1